Nat. Prod. Rep., 2000, 17(6), 603 - 620  
DOI: 10.1039/a904850b

Review Article


Quinoline, quinazoline and acridone alkaloids

Joseph P. Michael
Centre for Molecular Design, Department of Chemistry, University of the Witwatersrand, Wits 2050, South Africa E-mail: jmichael@aurum.chem.wits.ac.za

Received (in Cambridge, UK) 15th June 2000

Published on the Web 16th October 2000


Contents
1. Quinoline alkaloids
1.1 Occurrence
1.2 Non-terpenoid quinoline and quinolinone alkaloids from higher plants
1.3 Terpenoid quinoline alkaloids, tricyclic derivatives and dimeric analogues
1.4 Furoquinoline alkaloids
1.5 Decahydroquinoline alkaloids of the genus Lycopodium
1.6 Quinoline alkaloids from fungal and microbial sources
1.7 Quinoline alkaloids from animals
1.8 Decahydroquinoline alkaloids from ants and amphibians
2. Quinazoline alkaloids
2.1 Occurrence, characterisation and biological activity
2.2 Structural and synthetic studies
3. Acridone alkaloids
3.1 Occurrence and characterisation
3.2 Synthesis and biological studies

Covering: July 1998 to June 1999. Previous review: 1999, 16, 697.


1 Quinoline alkaloids

1.1 Occurrence

The new quinoline alkaloids reported in the period covered by this review are listed in
Table 1 together with their sources. 1–23 The Table also includes several known alkaloids isolated from new sources. Significant details pertaining to the characterisation of the new compounds are given in the appropriate sections of the ensuing discussion.

Table 1 Isolation and detection of quinoline alkaloids from microbial, plant and animal sources
Species
Alkaloid a
Ref
Casimiroa edulis 5-Hydroxy-1-methyl-2-phenylquinolin-4-one 1
4-Methoxy-1-methylquinolin-2-one
Clausena lansium 4-Methoxy-1-methylquinolin-2-one 2
Dictamnus dasycarpus Dictangustine-A b 41 3
Isodictamnine 46
Iso--fagarine b 42
N-Methylflindersine 38
Preskimmianine
Skimmianine
Evodia officinalis Dihydroevocarpine 4
Evocarpine
2-Hydroxy-4-methoxy-3-prenylquinoline 32 (see text)
1-Methyl-2-[(Z )-6-undecenyl]quinolin-4-one
Galipea officinalis Demethoxycusparine 6 5
()-Galipinine (Allocuspareine) b 2 5,6
Glycosmis arborea 4,8-Dimethoxy-1-methyl-3-prenylquinolin-2-one 7
(O-Methylglycosolone)
Glycosmis trichanthera Dictamnine 43 8
(= G. calcicola), root bark -Fagarine 44
N-Methylatanine
Skimmianine
Haliclona tulearensis (+)-Halitulin b 87 9
Mantella betsileo cis-Decahydroquinoline 195A 111 10
cis-Decahydroquinoline 195J b 112
Melicope ptelefolia (= Evodia lepta) Melicobisquinolinone A b 36 11
Melicobisquinolinone B b 37
N-Methylflindersine
Metrodorea flavida -Fagarine 12
Flindersiamine 13
Kokusaginine 12
Maculine
Photuris versicolor N-Methylquinolinium-2-carboxylate b 89 14
Ruta graveolens 2-(n-Decyl)-1-methylquinolin-4-one b 15 15
2-(n-Decyl)quinolin-4-one b 12
2-(n-Heptyl)quinolin-4-one 9
2-(n-Nonyl)quinolin-4-one 11
2-(n-Octyl)quinolin-4-one b 10
2-(n-Undecyl)-1-methylquinolin-4-one 16
Severinia (= Atalantia) buxifolia Severibuxine b 34 16
Skimmia laureola (+)-Methylisoplatydesmine b 35 17
Solenopsis (Diplorhoptrum) azteca Decahydroquinoline 5-epi-cis-275B b 97 18
Decahydroquinoline 5-epi-trans-275B b 98
Solenopsis (Diplorhoptrum) sp. picea group Decahydroquinoline cis-195A 111 10
Decahydroquinoline cis-195J b 112
Thamnosma africana N-Methylatanine 19
Toddalia asiatica Dictamnine 20
-Fagarine
Haplopine 45
Zanthoxylum integrifolium Atanine 33 21
Z. monophyllum -Fagarine 22
Skimmianine
Z. syncarpum Skimmianine 23
a Only new alkaloids and new records for a given species are listed in the table. Structures of most known alkaloids may be found in previous reviews in this series. b New alkaloids.


1.2 Non-terpenoid quinoline and quinolinone alkaloids from higher plants

Bioactivity-guided fractionation of an ethyl acetate extract of the seeds of Casimiroa edulis, a medicinal and food plant of Mexico and Central America, showed that the antimutagenic activity was due to the known alkaloid casimiroine 1, among other metabolites.
1 Casimiroine not only inhibited 7,12-dimethylbenz[a]anthracene (DMBA)-induced mutation of Salmonella typhimurium, but also displayed promising chemopreventive activity against cancer by significantly inhibiting DMBA-induced lesions in mouse mammary gland cultures.
Two investigations on the constituents of Angostura bark (Galipea officinalis), published within a few months of each other, have brought to light the new 1,2,3,4-tetrahydroquinoline alkaloid 2. The earlier publication assigned the name galipinine to the compound, 5 while the later publication, in which the isolation was based on bioactivity-guided fractionation against Mycobacterium tuberculosis, named it allocuspareine. 6 The former name should thus take precedence. The NMR spectroscopic data in the two publications are in broad agreement (H ± 0.3 ppm, C ± 2 ppm), although there are discrepancies in the assignment of signals. While galipinine was shown to be laevorotatory in the earlier study ([]D33.4, c 0.0055, CHCl3), a full CD spectrum reported in the latter study additionally proved that the new compound belongs to the same enantiomeric series as the related alkaloid cuspareine 3, the absolute configuration of which is not known. Cuspareine was in fact also isolated in both investigations, as well as two other well-known alkaloids, cusparine 4 and galipine 5. In addition, the presence of demethoxycusparine 6, not previously known from this plant source, was reported in the earlier article, while 4-methoxy-2-pentylquinoline 7 and N-methylquinolin-2-one 8 were detected in the latter investigation. Despite the authors claims to the contrary, alkaloid 8 is not a new natural product–it was, in fact, first detected in extracts of G. officinalis almost thirty years ago. 24 Both articles give previously unreported NMR spectroscopic data for cuspareine 3 and galipine 5. As a postscript in the second investigation, the quinoline alkaloids were found to be more active against M. tuberculosis than the tetrahydroquinoline alkaloids, but the bulk of the activity resided in the unidentified polar basic fraction from the bark extract.

Although quinolin-4-one alkaloids bearing hydrocarbon chains at C-2 are not uncommon metabolites of certain rutaceous plants, the chains invariably possess an odd number of carbon atoms. A suite of quinolin-4-one alkaloids 9–16 isolated from Ruta graveolens is thus unusual in including all chain lengths between C7 and C11. 15 The n-octyl and n-decyl compounds 10, 12 and 15 are new natural products, while 2-heptylquinolin-4-one 9 was previously known only as a metabolite of microorganisms of the genus Pseudomonas. Not all of the alkaloids were separable, but MS measurements in some cases, and reversed-phase HPLC–MS in others, provided good evidence for the structures.

In last years review, 25a it was pointed out that the ostensibly new alkaloid transitorine 17 from Ephedra transitoria was, in fact, merely the keto tautomer of the well-known compound kynurenic acid. This fact has now been recognised by the authors, 26 who have withdrawn the trivial name transitorine (which actually appeared as transtorine in the original publication 27 ) from the literature.
Oxidation of 2-aryl-1,2,3,4-tetrahydroquinolin-4-ones with a relatively safe hypervalent iodine reagent, [hydroxy(tosyloxy)iodo]benzene, in trimethyl orthoformate containing a trace of perchloric acid as catalyst provides a simple route to 2-aryl-4-methoxyquinolines, including the alkaloids 18 and 19 (graveolinine). 28 Radical cyclisation of the cis-stilbene-like precursor 20 with tributyltin hydride and AIBN in boiling benzene produced an equal mixture of the methyl ether 21 of the unusual benzo[h]quinoline alkaloid toddaquinoline and its regioisomer 22 in 58% yield. 29

(+)-Tortuosamine 23 and its N-formyl analogue 24 are atypical alkaloids from the genus Sceletium (Amaryllidaceae). New enantioselective syntheses of these tetrahydroquinolines proceeded through the ()-alcohol 25, for which three different routes from the corresponding achiral 1-arylcyclohexene were developed. 30 Some significant later steps in the synthesis are shown in Scheme 1. One of these is the free radical cyclisation and oxidation of the bromoacetal 26, which stereoselectively introduced the side chain adjacent to the aromatic ring into the product 27. After a series of functional group interconversions and transpositions, the -iodo enone 28 was subjected to palladium-mediated coupling with the diethyl acetal of propynal to give enyne 29, partial hydrogenation of which over Lindlar catalyst produced a mixture of dienes 30. Condensation of this mixture with ammonium acetate in acetic acid completed the construction of the tetrahydroquinoline core of the product 31, which was readily converted into the target alkaloids (+)-23 and (+)-24.

Scheme 1 Reagents: i, H2CCHOEt, NBS, Et2O, 0 °C to rt; ii, Bu3SnCl (cat.), NaBH4, AIBN (cat.), ButOH, reflux; iii, MCPBA, BF3·Et2O, CH2Cl2, rt; iv, Me2NH2Cl, Me3Al, THF, reflux; v, Swern oxidation; vi, LiAlH4, THF, reflux; vii, MeOCOCl, Et3N, CH2Cl2, rt; viii, CS2, NaH, MeI, THF, rt; ix, 1,2-Cl2C6H4, reflux; x, CrO3, 3,5-dimethylpyrazole, CH2Cl2, 15 °C; xi, I2, pyridine, CCl4, rt; xii, HCCCH(OEt)2, PdCl2(Ph3P)2 (cat.), CuI (cat.), Pri2NH, THF, 0 °C; xiii, H2, Lindlar catalyst, EtOAc, rt; xiv, NH4OAc, AcOH, 100 °C; xv, 50% KOH–EtOH (12) reflux; xvi, AcOCHO, 0 °C.

1.3 Terpenoid quinoline alkaloids, tricyclic derivatives and dimeric analogues

The ostensibly new alkaloid 2-hydroxy-4-methoxy-3-prenylquinoline 32, isolated along with several known quinoline and carbazolo[1,2-b]quinazoline alkaloids from the fruits of Evodia officinalis,
4 is actually the hydroxy tautomer of the rather rare quinolin-2-one alkaloid atanine 33. Confusion between hydroxyquinoline and quinolinone tautomers is a common pitfall for the unwary (cf.transitorine in the previous section), and the prevailing tautomer depends on the medium in which spectra are recorded. The alkaloids isolated in this study (see Table 1) showed marginal cytotoxic activity against both human lung and colon carcinoma cells, but were inactive as topoisomerase inhibitors. Atanine from Zanthoxylum integrifolium has also proved to be a good inhibitor of platelet aggregation in vitro, and exhibited a strong vasorelaxing effect on the contraction of rat aorta induced by potassium ions or norepinephrine. 21
Severibuxine 34, a new member of the extremely rare class of monoterpenoid quinolinone alkaloids, is the first quinolinone alkaloid to have been found in the Chinese plant Severinia buxifolia (Atalantia buxifolia). 16 The usual metabolites from this source are acridone alkaloids, a number of which were also isolated on this occasion. The new compound and its acetate derivative were characterised spectroscopically. Severibuxine proved to be cytotoxic against P-388 murine leukaemia and various other cell lines, as were most of the accompanying acridones.

Aerial parts of Skimmia laureola, a medicinal plant native to Kashmir and northern Pakistan, yielded the new dihydrofuro[2,3-b]quinoline alkaloid (+)-methylisoplatydesmine 35, which was characterised fully by spectroscopic techniques. 17 Its absolute configuration was not ascertained.
Two dimeric quinolinone alkaloids, melicobisquinolinones A and B, 36 and 37, were isolated from leaf extracts of the Vietnamese medicinal plant Melicope ptelefolia together with one of the constituent moieties, N-methylflindersine 38. 11 Dimers of prenylated quinolinone alkaloids are extremely uncommon, and most of them can be envisaged as formal Diels–Alder adducts formed from monomers such as N-methylflindersine and a prenylquinolinone precursor 39, as in the case of melicobisquinolinone A. Indeed, the new alkaloid 36 is a regioisomer of paraensidimerine D 40, another formal Diels–Alder adduct of 38 and 39, which has been known for almost two decades. Both 36 and 37 were characterised with the help of very thorough NMR spectroscopic studies in which two-dimensional correlations and NOE effects were used to establish connectivities and spatial relationships, as well as the half-chair or twisted conformations for the dihydropyran rings. Since neither of the bismelicoquinolinones showed Cotton effects in their CD spectra, they are thought to be racemic. Alkaloids 37 and 38 inhibited mycelial growth of the fungus Cladosporium cucumerinum at nanomolar concentrations, but 36 was inactive.

1.4 Furoquinoline alkaloids

The simple new furoquinoline alkaloids dictangustine-A 41 and iso--fagarine 42 were isolated from the root bark of Chinese Dictamnus angustifolius together with several other more common members of this class.
3 The positions of the substituents on ring A were determined by means of NOESY experiments.
Dictamnine 43, -fagarine 44 and haplopine 45, isolated from Toddalia asiatica by bioassay-guided fractionation, showed complete inhibitory activity at 100 g ml1 towards arachidonic acid-induced platelet aggregation in vitro. 20

A new synthetic approach to the furoquinoline alkaloids in which the key step involves rhodium-mediated dipolar cycloaddition of diazoquinolinediones is exemplified by the synthesis of isodictamnine 46 (Scheme 2). 31 Cycloaddition of the diazo compound 47 with trimethylsilylacetylene was catalysed by rhodium pivalate and a few drops of ethanolic hydrochloric acid in fluorobenzene at 55 °C, and gave the angular adduct 48 and the desired linear adduct 49 in yields of 57% and 18% respectively. Desilylation of the separable adducts with tetrabutylammonium fluoride afforded the unnatural compound pseudoisodictamnine 50 (87%) and the target alkaloid 46 (61%). In general, the ratio of angular to linear adducts was found to vary markedly depending on the diazo compound, the dipolarophile and the presence of hydrochloric acid. The method is thus unlikely to be generally useful for preparing naturally occurring furo[2,3-b]quinolines and related 2,3-dihydro analogues.

Scheme 2 Reagents: i, Et3N, MeSO2N3, EtOH, 0 °C to rt; ii, HCCSiMe3, Rh2(OCOCMe3)4 (0.01 mol%), cat. HCl in Et2O (1 M), C6H5F, 55 °C; iii, Bu4NF, THF (1 M), rt.

1.5 Decahydroquinoline alkaloids of the genus Lycopodium

Most of the alkaloids belonging to the genus Lycopodium (club-mosses) are polycyclic compounds commonly possessing C10N, C16N2 or C30N3 skeletons. However, several decahydroquinolines bearing additional heterocyclic rings as substituents are known. The structures of two of these compounds, lucidine A and oxolucidine A, have hitherto been only partially elucidated because of the complexity of their NMR spectra. A recent reinvestigation of the extracts of L. lucidulum has now resulted in the almost complete assignment of the structures.
32 Separation of four alkaloids, lucidines A and B and oxolucidines A and B, was achieved by countercurrent distribution followed by chromatography on alumina and, finally, reversed-phase HPLC. A chemical correlation between lucidines A and B and the two oxolucidines was established by formation of the latter two from the former on exposure to air. Oxolucidine A was reduced to a dihydro derivative upon treatment with sodium borohydride in methanol. An unusual tris( p-bromobenzoate) derivative of the reduced product gave crystals suitable for X-ray diffraction analysis, which revealed the structure 51, the absolute configuration of which is as depicted. The structures of lucidine A and oxolucidine A were thus inferred to be 52 and 53, respectively, and the only remaining uncertainty is the configuration of lucidine A at C-14. The structures of the compounds in the B series remain undetermined.

The simpler Lycopodium alkaloid Na-acetyl-Nb-methylphlegmarine 54 has been synthesised by Comins and co-workers by a route involving two different applications of their well-known methodology based on the use of chiral N-acylpyridinium salts as precursors for the preparation of versatile dihydropyridone intermediates (Scheme 3). 33 Firstly, stereoselective addition of (R)-2-methylpent-4-enylmagnesium chloride to the salt 55 gave the N-acyldihydropyridone 56 in 76% yield. Significant later steps included acid-induced intramolecular aldol condensation of keto-aldehyde 57 to create the hexahydroquinolin-4(1H )-one 58, stereoselective introduction of an axial substituent at C-5 by conjugate addition and trapping of the enolate to form the silylated enol triflate 59, and defunctionalisation of 59 with a palladium(0) catalyst and formic acid to yield the bridgehead alkene 60. The ensuing hydrogenation of the alkene took place predominantly (8911) on the face opposite to the silyl substituent, giving a trans-fused decahydroquinoline containing four of the target alkaloids five stereogenic centres. Oxidative desilylation of 61 and manipulation of substituents then completed the synthesis of the key 5-iodomethyldecahydroquinoline 62. Experience gained with model studies 34 suggested the transformation of 62 into the organomagnesium reagent 63, which was added to a second equivalent of the salt 55 to produce the new dihydropyridone 64 in 50% yield along with the product of methyl addition (50%). A single crystal X-ray structure determination of 64 confirmed that all five stereogenic centres had been correctly installed. The synthesis of alkaloid 54 was completed as shown in Scheme 3. This route, the first asymmetric synthesis of ()-Na-acetyl-Nb-methylphlegmarine, established the (2S, 4aR,5S,7R,8aR) absolute configuration of the alkaloid.

Scheme 3 Reagents: i, (R)-H2CCHCH2CH(Me)CH2MgCl, THF, 78 to 42 °C, then 10% aq. HCl; ii, NaOMe in MeOH (4.37 M), reflux; iii, 10% aq. HCl, THF, rt; iv, BuLi, THF, 78 °C; v, PhOCOCl, THF, 78 °C; vi, L-Selectride, BF3·Et2O, THF, 78 °C; vii, O3, MeOH, 78 °C, then Me2S, 78 °C to rt; viii, p-TsOH·H2O, C6H6, 40–50 °C; ix, PhMe2SiCH2MgCl, CuI, Et2O–THF, 0 °C to rt; x, N-(5-chloro-2-pyridyl)triflimide, DMPU, Et2O–THF, heat; xi, Bu3N, HCO2H, Ph3P, Pd(OAc)2, DMF, 60 °C; xii, KOH, PriOH–H2O, reflux; xiii, H2 (1 atm), 5% Pd/C, AcOH, EtOH, rt; xiv, BnOCOCl, NaOH (1 M), 0 °C to rt; xv, 35% MeCO3H in AcOH, Hg(OAc)2, rt; xvi, LiAlH4, THF, reflux; xvii, (Ph2PCH2)2, (CH2I)2, CH2Cl2, rt to reflux; xviii, ButLi (2 equiv.), Et2O, 78 to 45 °C; xix, MeMgBr (1 equiv.), Et2O; xx, salt 55, PhMe, 78 °C; xxi, AcCl, K2CO3, THF, rt; xxii, H2 (1 atm), 5% Pd/C, Li2CO3, EtOAc.

1.6 Quinoline alkaloids from fungal and microbial sources

It has been suggested that the biogenesis of the Streptomyces metabolite benzastatin D 65 from the simpler benzastatin A 66 is via an epoxide such as 67, which can undergo cyclisation to give either 65 or the alternative metabolite benzastatin E 68.
35 In model studies designed to probe these options, the epoxides 69 and 70 were found to give exclusively the indoline products 71 and 72 after catalytic hydrogenation over a 10% palladium-on-carbon catalyst. However, it is possible that benzastatins D and E interconvert through an aziridine intermediate. This hypothesis was tested by the model reaction sequence shown in Scheme 4. Treatment of the aniline derivative 73 with iodine yielded the 3-iodotetrahydroquinoline 74, which was converted into the aziridine 75 when exposed to DBU in toluene at 100 °C. Solvolysis of 75 with silver tetrafluoroborate in aqueous acetone yielded only the tetrahydroquinolin-3-ol 76, but treatment with anhydrous hydrogen chloride produced a 11 mixture of the alternative products 77 and 78.


Scheme 4 Reagents: i, I2, Na2CO3, CH2Cl2, rt; ii, DBU, PhMe, 100 °C; iii, AgBF4, Me2CO–H2O, rt; iv, dry HCl, CH2Cl2, rt.

Further studies aimed at the total synthesis of the broad-spectrum antibiotic and antitumour compound streptonigrin 79 have focused on coupling strategies for building the CD ring system. 36 The best results were achieved by means of Suzuki coupling between the boronic ester 80 and 4-chloro-3-nitropyridine [Pd(Ph3P)4, K2CO3, DME, reflux], which gave the model biaryl system 81 in 81% yield.

The first total synthesis of luzopeptins A–C 82–84, potent antitumour antibiotics isolated from the microorganism Actinomadura luzonensis almost twenty years ago, has been communicated by Boger and co-workers. 37 The challenges posed by the construction of the symmetrical decadepsipeptide core, obviously the main feature of the synthesis, will not be described here since they are only peripheral to the topic of this review. At the end of the synthesis, 3-hydroxy-6-methoxyquinoline-2-carboxylic acid was attached to free amine groups on the depsipeptide core by conventional amide formation to give luzopeptin C in 80% yield . Peracetylation followed by mild basic hydrolysis then yielded a mixture of luzopeptins A (50%) and B (20%). Ciufolini and co-workers have also described a synthetic approach to the luzopeptins in which the main objective was the assembly of the key tripeptide 85 in multigram amounts. 38
Boger and Saionz have reported further studies on the DNA-binding properties of the antitumour antibiotic sandramycin 86 and 23 synthetic analogues in which the intercalation chromophore was systematically varied 39 (cf. ref. 25b ). The surface plasmon resonance technique was used to establish binding constants to the high-affinity bis-intercalation binding site 5-(GCATGC)2, and to evaluate the preference for sandramycin binding to 5-d(GCXXGC)2 (X = AT, TA, CG, GC). In general, results paralleled those previously obtained by fluorescence quenching measurements, but in addition it was found that complexes formed at the high-affinity bis-intercalation sites were exceptionally stable, as judged by the unusually slow off rates for binding dissociation. This feature appears to correlate with previously observed cytotoxicity.

1.7 Quinoline alkaloids from animals

(+)-Halitulin, a marine metabolite possessing the unique 3,4-bis(quinolin-5-yl)pyrrole structure 87 (absolute configuration unknown), was isolated from the sponge Haliclona tulearensis collected in Sodwana Bay near Durban, South Africa.
9 This astonishing structure was revealed by a combination of spectroscopic and chemical analyses. In particular, the 7,8-dihydroxyquinoline unit, unprecedented in a natural product, was suggested by the formation of an unstable ortho-quinone on treatment with sodium periodate. Its position of attachment was inferred from NOE effects between 2-H on the pyrrole ring and 4-H and 6-H on the quinoline system. The azacyclodecane and aliphatic components were deduced after spectroscopic comparisons with haliclorensin 88, a simpler metabolite recently reported from the same sponge. Halitulin forms an unstable tetraacetate, and is oxidised on exposure to air and light to a mixture of two azacyclodecane N-oxides, after which quinone formation apparently occurs. The new alkaloid showed cytotoxic activity towards cell cultures of P-388 murine leukaemia, A-549 human lung carcinoma, HT-29 human colon carcinoma and MEL-28 human melanoma (IC50 0.025, 0.012, 0.012 and 0.025 g cm3, respectively).
The much simpler alkaloid N-methylquinolinium-2-carboxylate 89, a natural betaine isolated from whole-body extracts of the firefly Photuris versicolor, appears to participate in the insects arsenal of chemical defences against predators. 14 This is the first time that this known compound has been found as a natural product. The structure was deduced on the basis of its spectroscopic properties, and confirmed by synthesis following a reported procedure. 40

Jineol (quinoline-3,8-diol) 90, a cytotoxic alkaloid isolated from the centipede Scolopendra subspinipes, has been synthesised by a route in which directed ortho-lithiation of a 2-chloroquinoline is the principal step (Scheme 5). 41 8-Methoxyquinolin-2-one 91, prepared in three steps from o-anisidine, was converted into the 2-chloro derivative 92 by treatment with phosphorus oxychloride, following which lithiation with lithium tetramethylpiperidide and treatment with trimethyl borate afforded the quinoline-3-boronic acid 93 in 82% overall yield. Oxidation with peracetic acid to give the quinolin-3-ol 94 proceeded in excellent yield. Dechlorination of 94 with zinc in acetic acid followed by demethylation gave a poor overall yield (21%) of the target alkaloid 90, but the yield was improved to 46% by forming the methyl ether of 94 before carrying out the defunctionalisations. A number of ethers of jineol were also prepared for biological screening by alkylating 90 with haloalkanes in dimethyl sulfoxide containing powdered potassium hydroxide.

Scheme 5 Reagents: i, POCl3, pyridine (cat.), C6H5Cl, reflux; ii, LiTMP, THF, 75 °C; iii, B(OMe)3, THF, 75 °C, then H2O–THF; iv, MeCO3H (32%), HOAc, 0 °C to rt, then NaHSO3, H2O; v, Me2SO4, K2CO3, Me2CO, reflux; vi, Zn, HOAc, H2O, 70 °C; vii, pyridine·HCl, 200–220 °C.

1.8 Decahydroquinoline alkaloids from ants and amphibians

A major new survey of the alkaloidal constituents isolated from the skins of frogs, toads and related amphibians by Daly, Garraffo and Spande provides a snapshot of the current state of knowledge in this rapidly expanding area of investigation.
42 The section on 2,5-disubstituted cis- and trans-decahydroquinoline alkaloids, almost 40 of which have been partially or fully characterised to date, covers the occurrence, biological activity, synthesis and spectroscopic identification of these compounds, and gives valuable information on their IR and MS behaviour in particular. Also mentioned briefly are some tentative tetrahydroquinoline and octahydroquinoline variants, and putative Diels–Alder dimers of the latter. The smaller family of gephyrotoxins, which possess a perhydropyrrolo[1,2-a]quinoline core, is dealt with separately.
The hypothesis that most of the skin alkaloids of amphibians are derived from dietary sources has received a fillip from the discovery of decahydroquinoline alkaloids in ants, reported in two recent papers. Extracts from virgin queens of the myrmicine ant Solenopsis (Diplorhoptrum) azteca from Puerto Rico contained two new caste-specific alkaloids of molecular mass 275 in the ratio 19. 18 Mass spectrometric fragmentation patterns and FTIR spectra showed beyond doubt that these were decahydroquinolines bearing unsaturated side chains – the first compounds of this class ever detected in ants. Two related alkaloids of the same molecular mass isolated from Costa Rican populations of the frog Dendrobates pumilio had been known for some years, but had never previously been obtained in sufficient quantity for characterisation. Valuable spectroscopic comparisons between the four compounds proved that they were diastereomeric; in particular, the stereochemical relationships were inferred largely on the basis of Bohlmann bands and fingerprint absorptions in the IR spectra. The upshot is that the frog alkaloids (decahydroquinolines cis-275B and cis-275B) have been assigned the structures 95 and 96, respectively, while the new ant alkaloids (coded as 5-epi-cis-275B and 5-epi-trans-275B) are 97 and 98. A substantial 1H and 13C NMR spectroscopic study of cis-275B 95 and its deuterium chloride salt, and extensive comparisons with synthetic model systems, permitted the determination of an N-endo conformation, as illustrated in 99.

Furthermore, accumulated experience and recent advances in spectroscopic interpretation also allowed the authors to clarify the structures of several other amphibian decahydroquinolines that have hitherto been only tentatively identified. 13C NMR spectroscopic data were obtained for the first time for cis-243A 100 from D. auratus; the N-exo conformation 101, with the C-2 substituent equatorial and the C-5 substituent axial, appears to be favoured. The structure of trans-269AB from D. pumilio and various populations of D. histrionicus– actually, an inseparable mixture of 102 and its C-5 epimer 103– was also based partly on NMR spectroscopic measurements, and is comparatively secure. Several minor stereoisomers in the 269AB complex have not yet been clarified, although a related compound from Costa Rican D. granuliferus seems to be an isomer of cis-269AB 104. Some residual uncertainty also hangs over the configuration at C-5 of alkaloids trans-269A 105 and trans-269B 106 from D. auratus. A population of D. pumilio from Isla Colón, Panama produced the partly characterised cis-267L 107, while a suite of decahydroquinolines of molecular mass 271 from D. granuliferus appeared to include cis-271D 108 and trans-271D 109 (in both of which the C-2 and C-5 side-chains might be interchanged), and iso-5-epi-trans-271D 110. The paper contains a useful list of 36 known and tentative decahydroquinoline alkaloids and their amphibian sources.

A Brazilian myrmicine ant species belonging to the Solenopsis (Diplorhoptrum) sp. picea group was found to contain three structurally isomeric alkaloids in the ratio 311. 10 The major component proved to be identical to a known amphibian 4-methyl-6-propylquinolizidine (also known as quinolizidine 195C). The minor components, characterised by GC-MS behaviour and FTIR spectroscopy, proved to be the well-known frog alkaloid cis-195A 111 (the inappropriately-named pumiliotoxin C, or cis-fused 5-methyl-2-propyldecahydroquinoline; vide infra) and a hitherto unknown stereoisomer. This isomer showed fingerprint absorptions in the IR spectrum typical of a cis-fused decahydroquinoline, as well as a Bohlmann band pattern indicative of cis-disposed hydrogen substituents at C-2 and C-8. The relative stereochemistry at C-5 was not determined. Structure 112 was proposed for the new product, which has been assigned the code designation cis-195J. Significantly, small quantities of the same triad of alkaloids have been found, among several others, in a number of populations of the Madagascan mantelline frog Mantella betsileo, which strongly suggests that ants related to the Brazilian species are likely dietary sources of the sequestered skin alkaloids.
An important communication by the Daly team describes the use of chemical ionisation tandem mass spectrometry (CI-MS/MS) with ammonia as the reagent gas for elucidating the structures of several classes of monocyclic and bicyclic amphibian alkaloids, including decahydroquinolines. 43 The collision-induced dissociation of the initially generated [M + H]+ ion, which is incapable of releasing a radical, results in markedly different fragmentation pathways when compared to conventional electron-impact methods, and casts new light on the structures of the alkaloids. The CI-MS/MS spectra of cis-195A 111 and cis-219A 113 were given to illustrate the application of the technique to decahydroquinoline systems.

Decahydroquinoline cis-195A, still referred to as pumiliotoxin C by most synthetic chemists (to the chagrin of the Daly group 42 ), is the prototypical decahydroquinoline alkaloid from the skin secretions of dendrobatid frogs, and it remains a very popular target for synthesis. Some years ago, Back and Nakajima reported a short synthesis of the racemic alkaloid 44 (cf. ref. 25c ); this route has now been modified as shown in Scheme 6 to yield the ()-enantiomer 111. 45 The key to enantioselectivity lay in the selective hydrolysis of the racemic diester 114 with pig liver esterase to give a 11 mixture of the two half-esters 115 and 116. Although these compounds were difficult to separate, a combination of chemical transformations and recycling allowed recovery of the latter in a total yield of 67%. The ()-half ester 116 was converted in four steps into the ()-amino ester 117, following which syntheses of ()-111 and the epimeric compound 2-epi-pumiliotoxin C 118 were completed via the bicyclic enaminone (+)-119 by means of the methodology previously used for making the racemic compounds.

Scheme 6 Reagents: i, pig liver esterase, phosphate buffer (pH 8), rt; ii, CH2N2 in Et2O, MeOH; iii, NaOH, H2O, reflux, then HCl; iv, Ph2PON3, Et3N, PhMe, reflux; v, BnOH, pyridine, reflux; vi, H2 (1 atm), 10% Pd/C, HCO2H, MeOH, rt; vii, EtOH, rt; viii, LDA, THF, 78 °C to rt; ix, Tf2O, CH2Cl2, reflux; x, H2 (100 atm), PtO2, MeOH, 6 d; xi, BnOCOCl, aq. K2CO3, CHCl3; xii, 5% Na–Hg, Na2HPO4, MeOH–THF (11), rt; xiii, H2 (1 atm), 10% Pd/C, EtOH, rt.

Short complementary syntheses of ()-pumiliotoxin C and several of its stereoisomers, devised by Habermehl and co-workers, 46 are illustrated in Scheme 7. Condensation of the kinetically-generated enolate of (R)-(+)-3-methylcyclohexanone 120 with diethyl carbonate yielded the keto ester 121, after which reaction with (S)-(+)-3-aminohexanol 122 produced the 3-aminoacrylate 123. Sequential replacement of the hydroxy group by tosylate and bromide gave 124, stereoselective cyclisation of which was effected in 87% yield merely by heating in degassed DMF at 100 °C. The stereochemistry at C-4a in the product 125 is probably a result of steric effects during cyclisation. Removal of the ethoxycarbonyl blocking group was accomplished by heating 125 under reflux in a mixture of acetic acid, hydrochloric acid and pyridine. The imine functionality of the product 126 was hydrogenated over palladium on charcoal to produce a mixture of ()-pumiliotoxin C 111 and the ()-trans-fused epimer 127 in a ratio of about 10.64 and an overall yield of 57% based on 123. Epimerisation of the propyl chain in the latter product was probably caused by isomerisation of the imine in the presence of the palladium catalyst. The products could be separated by chromatography on alumina, but characterisation, including X-ray crystallographic analysis, was performed on the more stable hydrochloride salts. The trans compound would appear to be the same as the minor frog alkaloid trans-195A, the stereochemistry at C-5 of which was previously undetermined, but which has now apparently been clarified. 42 In the same manner, the aminoacrylate 128, prepared from (R)-(+)-3-methylcyclohexanone 120 and (R)-()-3-aminohexanol ent-122, was transformed into a mixture of 127 and the new cis-fused pumiliotoxin C isomer 129. Finally, aminoacrylate 130, derived from (S)-()-3-methylcyclohexanone ent-120 and (S)-(+)-3-aminohexanol 122, yielded another new cis-fused stereoisomer 131 as well as ent-127, the enantiomer of the trans-fused product.

Scheme 7 Reagents: i, (EtO)2CO, LDA, THF, 78 °C to rt; ii, TFA (cat.), 4Å molecular sieves, PhMe, 100 °C; iii, p-TolSO2Cl, DMAP, CH2Cl2, rt; iv, NaBr, DMF, rt; v, DMF, 4Å molecular sieves, 100 °C; vi, HOAc, pyridine, 20% aq. HCl, reflux; vii, H2, 10% Pd/C, EtOH, then chromatography on Al2O3 (activity grade III).

Another approach that resulted in the synthesis of both cis-and trans-fused decahydroquinolines of the pumiliotoxin C class employed 2,3,4,6-tetra-O-pivaloyl--D-galactosamine 132 as an unusual chiral auxiliary (Scheme 8). 47 The imine 133 derived from reaction between this sugar derivative and hex-5-enal underwent a stereoselective Diels–Alder cycloaddition with 1-methoxy-3-trimethylsilyloxybutadiene to give the dihydropiperidin-4-one 134 in 68% yield and a diastereomeric ratio (dr) of better than 401. A sequence of reactions similar to those used in the Comins Lycopodium synthesis (cf. Section 1.5, Scheme 3) produced the pivotal bicyclic enone 135, after which stereoselective conjugate addition with lithium dimethylcuprate in the presence of trimethylsilyl chloride afforded the trans-fused decahydroquinolin-4-one 136 (81%, dr > 151). The structure of this product was substantiated by X-ray crystallography. The chiral auxiliary was removed with aqueous acid, after which standard transformations completed the synthesis of the hydrochloride salt of 137, which is yet another stereoisomer of pumiliotoxin C. The interesting feature of this route is that the chiral auxiliary apparently steers the protonation of the enolate formed from 135 by conjugate addition. When the sugar moiety of 135 was replaced by phenoxycarbonyl to give 138, the subsequent reaction with methylcuprate yielded the cis-fused product 139 in 82% yield and a dr of 4.51. Both 138 and 139 had previously featured in a synthesis of pumiliotoxin C by Comins and Dehghani. 48

Scheme 8 Reagents: i, hex-5-enal, 4Å molecular sieves, pentane; ii, 1-methoxy-3-trimethylsilyloxybutadiene, ZnCl2·Et2O, THF, 20 °C; iii, PrMgCl, CuCl, BF3·Et2O, THF, 78 °C; iv, NaIO4, K2OsO4 (cat.), aq. dioxane; v, NaOH, dibenzo-18-crown-6, C6H6; vi, Me2CuLi, Me3SiCl, THF, 78 °C; vii, Bu4NF; viii, HCl (1 M), aq. MeOH (15); ix, BnOCOCl, NaHCO3; x, (CH2SH)2, BF3·Et2O; xi, H2, Raney Ni; xii, HCl; xiii, PhOCOCl.

The first enantioselective total synthesis of the marine decahydroquinoline alkaloid lepadin B 140, a metabolite of the tunicate (sea-squirt) Clavelina lepadiformis, has been achieved by Toyooka et al. as shown in Scheme 9. 49 These workers once again commenced with the chiral building block 141, which has featured in several of their previous alkaloid syntheses. In this case, the building block was converted in a number of steps into the vinyl triflate 142 (48% overall yield), which underwent palladium-catalysed methoxycarbonylation to produce the unsaturated ester 143. The ensuing conjugate addition of a vinyl group gave the 2,3-trans-substituted ester 144 as a single isomer. After a series of standard transformations, the crucial intramolecular aldol condensation of keto-aldehyde 145 was achieved with DBU in boiling benzene. Some epimerisation of the aldehyde also occurred under these conditions, and the cis-fused bicyclic enone 146 was isolated in 60% yield as a 141 mixture with the trans-fused isomer. Conjugate addition of phenylthiomethyl phenyl sulfone at C-5 was followed by a series of defunctionalisations to give the sulfone-containing decahydroquinoline 147. To complete the synthesis, Julia coupling of 147 with 2-heptenal followed by removal of the remaining protecting groups yielded lepadin B 140. The spectra of the laevorotatory trifluoroacetate salt of the synthetic product ([]D 26 92.6, MeOH) were identical with those of the salt of natural lepadin B ([]D96, MeOH). This synthesis verifies the (2S,3S,4aS,5S,8aR) absolute configuration of ()-140.

Scheme 9 Reagents: i, Pd(PPh3)4, PPh3, Et3N, MeOH, CO (balloon), DMF, rt; ii, H2CCHLi, CuI, Et2O, 78 to 30 °C; iii, LiOH·H2O, MeOH–H2O (31), 60 °C; iv, EtOCOCl, Et3N, THF, 0 °C; v, CH2N2, Et2O; vi, PhCO2Ag, Et3N, Et2O; vii, Im2CO, Et3N, MeONHMe·HCl, CH2Cl2, 0 °C to rt; viii, MeMgBr, THF, 0 °C to rt; ix, OsO4, NaIO4, dioxane–H2O (11), rt; x, DBU (4 equiv.), C6H6, reflux; xi, PhSCH2SO2Ph, BuLi, THF, 78 to 10 °C; xii, Bu3SnH, AIBN, C6H6, reflux; xiii, NaBH4, MeOH–CH2Cl2 (110), 0 °C; xiv, Im2CS, (CH2Cl)2, reflux; xv, Bu3SnH, PhMe, reflux; xvi, PrSLi, HMPA–THF, rt; xvii, (Boc)2O, C6H6, reflux; xviii, BuLi, THF, 78 °C, then 2-heptenal, 78 to 50 °C; xix, Na–Hg, Na2HPO4, MeOH, rt; xx, conc. HCl, MeOH, reflux.

2 Quinazoline alkaloids

2.1 Occurrence, characterisation and biological activity

New quinazoline alkaloids isolated during the period under review are listed in
Table 2 together with known alkaloids isolated from new sources. 4,21,50–56

Table 2 Isolation and detection of quinazoline alkaloids
Species
Alkaloid a
Ref
Aspergillus ochraceus ()-Circumdatin C b 151 50
()-Circumdatin D b 152 51
()-Circumdatin E b 153
()-Circumdatin F b 154
Calanthe aristurifera, Tryptanthrin 165 52
C. discolor, C. reflexa
Evodia officinalis Evodiamine 4
Rutaecarpine 161
Glycosmis cf. chlorosperma (E )-Bogorin b 150 53
(Z )-Bogorin b 148
Penicillium sclerotigenum Sclerotigenin b 157 54
Penicillium thymicola (+)-Alantrypinone b 158 55
()-Fumiquinazoline F 159
Phellodendron amurense ()-7,8-Dihydroxyrutaecarpine b 56
(callus cultures) 162
(+)-7-Hydroxyrutaecarpine 161
Zanthoxylum integrifolium 14-Formylrutaecarpine 21
a Only new alkaloids and new records for a given species are listed in the table. Structures of most known alkaloids may be found in previous reviews in this series. b New alkaloids.


(Z )-Bogorin 148, a new quinazolone alkaloid isolated from Javanese Glycosmis cf. chlorosperma, was obtained in quantities too small for confirmation of its structure by two-dimensional NMR spectroscopic experiments. 53 The putative structure was therefore substantiated by the short synthesis shown in Scheme 10. Base-induced elimination of hydrogen chloride from 149 produced exclusively (E )-bogorin 150, which proved to be identical to another trace alkaloid in the plant extract. Photochemical isomerisation of 150 yielded a separable 11 mixture of (E )- and (Z )-bogorins, the latter of which gave 1H and 13C NMR spectroscopic signals identical to those of natural 148. (Z )-Bogorin showed antifungal activity towards Cladosporum herbarium (IC50 40 g cm3), and was moderately cytotoxic towards Artemia salina (brine shrimp). The (E )-isomer and the synthetic precursors were significantly less active.

Scheme 10 Reagents: i, 130 °C, 2.5 h; ii, styrene oxide, pyridine (cat.), PriOH, reflux; iii, SOCl2, C6H6, reflux; iv, DBU, C6H6, reflux; v, h (high pressure Hg lamp), cyclohexane, rt.

New peptide-like quinazolinone alkaloids derived from anthranilic acid together with other simple amino acids continue to turn up in fungal extracts. Circumdatin C 151 and the minor metabolites 152–154, named circumdatins D, E and F respectively, are quinazolino[3,2-a][1,4]benzodiazepinediones from a terrestrial isolate of Aspergillus ochraceus (subgenus Circumdati, section Circumdati). 50,51 The compounds, formally biosynthesised from two substituted anthranilate units and either L-alanine or L-proline, were accompanied by two unusual zwitterionic benzodiazepines, circumdatins A 155 and B 156. All structures were elucidated on the basis of spectroscopic measurements, with two-dimensional NMR experiments playing the expected dominant role. The simpler quinazolinobenzodiazepine sclerotigenin 157, obtained from extracts of the sclerotia (reproductive structures) of Penicillium sclerotigenum, is derived from anthranilic acid and glycine. 54 This compound, which first appeared in the literature over twenty years ago as a purely synthetic material, 57 gave NMR spectra at ambient temperatures consistent with the presence of atropisomers, a phenomenon that has been observed with related 1,4-benzodiazepines. Variable temperature NMR measurements indicated an interconversion barrier of about 20 kcal mol1. Sclerotigenin appears to be largely responsible for the observed antiinsectan activity of the fungal extract towards the crop pest Helicoverpa zea (the corn earworm).

Two major metabolites isolated from a new Penicillium species, P. thymicola, are the novel alkaloid, (+)-alantrypinone 158 and a known compound, fumiquinazoline F 159. 55 In addition to the usual complement of spectroscopic methods used for characterising the new compound, X-ray crystallographic analysis revealed the (3R,14R) absolute configuration shown in 158. The implication is that alantrypinone incorporates L-alanine and the unusual amino acid D-tryptophan, as do fumiquinazoline F and the closely related spiroquinazoline 160. The authors feel, however, that modular peptide synthases are probably responsible for the biosynthesis of these compounds, and that the configuration of the more likely precursor L-tryptophan is reversed during an enzymatic reaction.

Callus cultures of Phellodendron amurense, the bark of which is used as a traditional medicine in China, produce indolopyridoquinazoline alkaloids related to the well-known compound rutaecarpine 161. In the latest investigation of the chemical constituents of the cultures, the new metabolite ()-7,8-dihydroxyrutaecarpine 162 and a known alkaloid, (+)-7-hydroxyrutaecarpine 163, were isolated from methanolic extracts of callus tissue. 56 The only noteworthy feature in an otherwise unexceptional spectroscopic structural elucidation was the relatively small coupling constant between 7-H and 8-H (J 2 Hz), which suggests a trans-diequatorial arrangement of these protons, and hence a trans-diaxial arrangement of the two hydroxy groups.

The rather uncommon quinazoline alkaloid arborine 164 has been identified as the component responsible for the inhibition of juvenile hormone III-biosynthesis in the field cricket (Gryllus bimaculatus) by leaf extracts of Glycosmis pentaphylla. 58 A review on the search for natural products and analogues with antitubercular activity has once again highlighted the importance of tryptanthrin 165 as a lead compound. 59

2.2 Structural and synthetic studies

A recent book chapter dealing with applications of transition metal-catalysed carbonylations in the synthesis of alkaloids includes a short section on quinazoline alkaloids.
60
In 1996 Joshi et al. indisputably demonstrated the (3S) absolute configuration of ()-vasicinone 166 by means of X-ray crystallography, but reported that NMR spectroscopic analysis of the (+)- and ()-Moshers esters of the alkaloid gave a contradictory result 61 (cf. ref. 25d ). They have now acknowledged that they fell into the trap of assuming that, for example, the (R)-Moshers acid chloride [-methoxy--(trifluoromethyl)phenylacetyl chloride] gives rise to an ester that also has the (R) configuration. 62 In fact, in terms of the Cahn–Ingold–Prelog sequence rules, the ester must have (S) configuration because the priorities of the substituents change once chlorine is replaced by oxygen. There is thus no contradiction in the results from the spectroscopic analysis of the Moshers esters, and the (3S) configuration of ()-vasicinone has been fully vindicated. NMR spectroscopic analysis of the (+)- and ()-Moshers esters of ()-vasicine 167 likewise confirms that this alkaloid, too, has the (3S) configuration.

The alkaloids febrifugine and isofebrifugine, first reported over fifty years ago, have moved into the limelight recently in view of their powerful antimalarial activity. The natural products have long been assumed to have the (2S,3R) and (2R,3R) absolute configurations, respectively. However, the first asymmetric total synthesis of the two alkaloids, by Kobayashi et al., has now shown that these absolute configurations must be reversed. 63 Part of their synthesis of (2S,3R)-febrifugine is shown in Scheme 11. Condensation between 2-methoxyaniline, 2-methoxypropene and the (R)-aldehyde 168 (prepared by an enantioselective tin-mediated aldol condensation) was catalysed by ytterbium(III) triflate in aqueous medium, and gave the Mannich-type adducts 169 and 170 in 92% yield and a ratio of 3367. The anti adduct 169 was converted in several steps into the bromomethyl ketone 171, reaction of which with the anion of 4(3H )-quinazolinone (4-hydroxyquinazoline) followed by removal of the protecting groups completed the synthesis of the ()-enantiomer of febrifugine, ent-172. Natural febrifugine is dextrorotatory, and therefore must have the (2R,3S) configuration. By commencing with the (S)-enantiomer of aldehyde 168, the authors were able to prepare (2R,3S)-(+)-febrifugine 172, the data for which were identical in all respects with those reported for the natural product. A similar sequence of reactions on the syn-diastereomer 170 led to the formation of unnatural (2R,3R)-isofebrifugine ent-173, while the natural enantiomer 173 was once again obtained when the (S)-aldehyde ent-168 was used in the synthesis.

Scheme 11 Reagents: i, Yb(OTf )3 (10%), THF–H2O (91), 0–5 °C; ii, HF, THF; iii, Ph3P, CBr4, CH2Cl2; iv, CAN, MeCN, H2O, 0 °C; v, Boc2O; vi, LiN(SiMe3)2, THF, then Me3SiCl; vii, MCPBA, CH2Cl2; viii, 4-hydroxyquinazoline, KOH; ix, HCl (6 M), reflux; x, Br2, HBr, HOAc.

The synthesis of racemic febrifugine and isofebrifugine by Takeuchi and co-workers shown in Scheme 12 employed an unusual Claisen rearrangement for the construction of the piperidinol segment. 64 The allyl enol ether 174, prepared in four steps from 3-hydroxypyridine, rearranged in 74% yield to give the 2-allylpiperidin-3-one 175 merely on treatment with boron trifluoride etherate in acetonitrile at room temperature; rearrangement of the endocyclic double bond obviously precedes the Claisen rearrangement. Reduction of 175 with sodium borohydride in methanol gave the cis-2,3-disubstituted piperidin-3-ol 176 as the sole product. Bromoetherification then afforded the bicyclic compound 177 as a 31 mixture of diastereomers, an unimportant factor in view of the subsequent dehydrobromination to 178 under basic conditions. Bromohydration of 178 and reaction with 4(3H )-quinazolinone followed by removal of protecting groups completed the synthesis of (±)-isofebrifugine rac-173, following which thermal equilibration in boiling ethanol afforded (±)-febrifugine rac-172.

Scheme 12 Reagents: i, PhCH2Cl, PhMe, reflux; ii, H2CCHCH2Br, NaH, MeOH, reflux; iii, NaBH4, MeOH, 0 °C; iv, BnOCOCl, THF, rt; v, BF3·Et2O, MeCN, rt; vi, NBS, dry MeCN, rt; vii, ButOK, THF, reflux; viii, NBS, MeCN, H2O, rt; ix, 4(3H )-quinazolinone, K2CO3, DMF, rt; x, H2, 20% Pd(OH)2/C, MeOH, rt; xi, EtOH, reflux, 2 h.

The recently discovered quino[2,33,4]pyrrolo[2,1-b]quinazolinone alkaloid luotonin A 179 bears a striking structural similarity to the topoisomerase I inhibitor camptothecin 180, derivatives of which are used clinically for cancer chemotherapy. This structural similarity seems to underlie recent interest in the new alkaloid, which is effective against the murine leukaemia P-388 cell line (cf. ref. 25e ). Luotonin A has rapidly succumbed to synthesis, and two short approaches published during the period under review are shown in Scheme 13. The first, by Wang and Ganesan, 65 employed the known lactam 181, made in five steps and 9% overall yield from 2-nitrobenzaldehyde. Simple treatment of the anion of 181 with 2-sulfinylaminobenzoyl chloride 182 gave the target alkaloid 179 in 85% yield. The route devised by Kelly and co-workers 66 commenced with synthetic vasicinone (±)-166, prepared according to reported methods. Oxidation with Jones reagent afforded dione 183, which underwent a Friedlander condensation with 2-aminobenzaldehyde to give luotonin A 179 in 36% yield.

Scheme 13 Reagents: i, LiN(SiMe3)2 (4.9 equiv.), THF, 182 (2.1 equiv.), rt, 2 h, then LiN(SiMe3)2 (2.5 equiv.), 182 (1.1 equiv.), rt, 1 h; ii, Jones oxidation; iii, 2-aminobenzaldehyde, Triton B, EtOH, reflux.

Syntheses of ()-benzomalvin A 184 and benzomalvin B 185 by Eguchi and co-workers featured what has become known as the Eguchi protocol (acylation of suitable precursors with 2-azidobenzoyl chloride 186 followed by intramolecular aza-Wittig reaction) to construct both heterocyclic rings (Scheme 14). 67 The present work expands on a previously published communication 68 (cf. ref. 25f ), but includes noteworthy new results. In brief, reaction of 186 with N-methyl-L-phenylalanine methyl ester 187 yielded the intermediate azide 188 (ee 99.7%), after which treatment with tributylphosphine in boiling toluene followed by acidic work-up yielded the ()-benzodiazepinedione 189 in 87% yield and undiminished optical purity. A second application of the Eguchi protocol completed the synthesis of ()-benzomalvin A 184 ([]D 21 109.8, c 1.0, MeOH). Incidentally, the claim that this is the first total synthesis of ()-benzomalvin A is incorrect (vide infra). Benzomalvin B 185 was prepared from benzomalvin A as a mixture of (E ) and (Z ) isomers by a benzylic bromination–dehydrobromination sequence. An interesting feature of this study is that the conformation of benzomalvin A was found to change with time when studied by NMR spectroscopy, eventually attaining an equilibrium ratio of 7624. The major conformer was identical with the natural product. NOE interactions between the N-methyl group and H-7 suggested the conformations shown in 190 and 191 for the major and minor invertomers respectively. Furthermore, an X-ray crystallographic study on a crystal of the minor conformer, which proved to be dextrorotatory ([]D 23 +77.1, c 1.0, MeOH), confirmed the relative orientation of the diazepinone ring. The energy barrier between the two conformers was determined to be 5.9 kcal mol1 by PM3 calculations. What is not clear from this work is whether the minor conformer is actually the same as (+)-benzomalvin D, a minor Penicillium metabolite reported in 1995 69 (cf. ref. 25g ). Benzomalvin D was reported as displaying exactly the same kind of conformational interconversion with natural and synthetic samples of ()-benzomalvin A as described by the Eguchi group, and conformational representations essentially the same as those illustrated in 190 and 191 (which are, in effect, atropisomers) were proposed. The authors of the present publication seem not to have been aware of these results, and it appears that they may have unwittingly synthesised benzomalvin D in the course of their work.

Scheme 14 Reagents: i, Et3N, THF, 0 °C to rt; ii, Bu3P, PhMe, rt to reflux; iii, TFA–H2O–THF (1112.5), rt; iv, KN(SiMe3)2, THF, 78 °C; v, 186, THF, 78 °C to rt; vi, Ph3P, PhMe, rt to reflux; vii, NBS, AIBN, CCl4, reflux; viii, DBU, PhMe, reflux.

Wang and Ganesan recently reported a synthesis of fumiquinazoline G 192 in which cyclisation of the N-acylanthranilamide 193 to the 4-quinazolinone 194 was the key step 70 (cf. ref. 25f ). He and Snider have now shown that the cyclisation does not produce the lactam 194, but instead gives the lactim ether 195 (Scheme 15). 71 However, this does not invalidate the earlier study, since removal of the Fmoc protecting group with piperidine followed by chromatography on silica gel was accompanied by spontaneous cyclisation to yield fumiquinazoline G. Interestingly, removal of the Fmoc group with 4-dimethylaminopyridine yielded a free primary amine that failed to cyclise to the target alkaloid. With the aid of model studies, He and Snider were able to demonstrate that piperidine plays a role in the cyclisation over and above that of a deprotection agent. In their hands, an amidine carboxamide 196 proved to be an isolable intermediate. Exposure of this compound to silica gel induced spontaneous cyclisation to fumiquinazoline G through the putative quinazolinone intermediate 197.

Scheme 15 Reagents: i, Ph3P, I2, Pri2NEt, CH2Cl2, rt; ii, 20% piperidine in CH2Cl2, rt, then preparative TLC on SiO2; iii, piperidine, EtOAc, rt; iv, SiO2, EtOAc–MeOH (21), rt.

Several model studies designed to explore aspects of the synthesis of complex quinazoline alkaloids should be mentioned in conclusion. Synthetic approaches to the pyrazino[2,1-b]quinazoline core found in the ardeemins, fiscalins and fumiquinazolines have been evaluated by Cledera et al., who showed that the Eguchi protocol was the best of the four approaches studied for making products such as 198. 72 Hart and Magomedov have examined an unusual cascade reaction in which the sulfoxide 199 rearranged to a mixture of products that included the spiroindoline 200 upon treatment with trifluoroacetic acid in chloroform. 73 The ultimate intention is to apply the novel process to the synthesis of the alkaloid spiroquinazoline 160. On a simpler note, the benzodiazepinediones 201 were found to undergo rearrangement to the vasicinone-like carboxylic acids 202 in yields of 70–80% when heated in concentrated hydrochloric acid for a few minutes. 74

3 Acridone alkaloids

3.1 Occurrence and characterisation

A list of new acridone alkaloids, and known acridones isolated from new sources, is presented in
Table 3. 8,16,75–79 The 13C NMR spectrum of citpressine-I 203 has been reported for the first time, while certain reported 13C NMR spectroscopic assignments for the pyrano[2,3-c]acridone 204 have been corrected. 75 The latter compound showed some antispasmodic activity by inhibiting acetylcholine-induced contraction on rabbit intestinal tissue. The known compound furacridone 205 is the first acridone alkaloid to have been isolated from the genus Piper (pepper) and, indeed, from the family Piperaceae. 79


Table 3 Isolation and detection of acridone alkaloids
Species
Alkaloid a
Ref
Citrus deliciosa Citpressine-I 203 75
6,11-Dihydroxy-10-methoxy-3,3,12-trimethyl-
3,12-dihydro-7H-pyrano[2,3-c]acridin-7-one 204
Citrus paradisi Citbismine-F b 206 76
(+)-Neoacrimarine-H b 208 77
()-Neoacrimarine-I b 209
()-Neoacrimarine-J b 210
Neoacrimarine-K b 211
Glycosmis trichanthera N-Desmethylnoracronycine 242 8
(= G. calcicola), stem bark 5-Hydroxynoracronycine 212
Junosine
N-Methylatalaphylline
N-Methylatalaphyllinine 240
Yukocitrine
Melicope micrococca Arborinine 78
Piper pedicellosum Furacridone 205 79
Severinia (= Atalantia) buxifolia Atalaphylline 16
a Only new alkaloids and new records for a given species are listed in the table. Structures of most known alkaloids may be found in previous reviews in this series. b New alkaloids.


The new dimeric acridone alkaloid citbismine-F 206 was isolated as an optically inactive crystalline compound from the roots of Citrus paradisi (Marsh grapefruit), and characterised with the assistance of the expected battery of one- and two-dimensional NMR spectroscopic techniques. 76 The alkaloid contains a dihydrofuro[2,3-c]acridone moiety that is not known as a natural product in its own right; the other constituent of the dimer is the well-known alkaloid citpressine-II 207. The same plant species has also yielded four new acridone–coumarin dimers of the neoacrimarine class, viz. (+)-neoacrimarine-H 208, ()-neoacrimarine-I 209, ()-neoacrimarine-J 210, and the optically inactive neoacrimarine-K 211. 77 The nitrogen-containing moieties in 208–211 are 5-hydroxynoracronycine 212, grandisine-I 213, the previously unknown des-6-O-methyl analogue of grandisine-I 214 and citpressine-II 207, respectively, while the coumarin units are cis-khellactone 215 in the first three alkaloids and columbianetin 216 in the fourth. The connectivities were established by means of NMR spectroscopic analyses, in particular heteronuclear multiple-bond correlation (HMBC) and NOE experiments. The absolute configurations of the alkaloids were not determined, but it is suspected that the observed optical rotations may indicate that neoacrimarine-H has the opposite stereostructure to neoacrimarines-I and -J in the cis-khellactone moiety.


3.2 Synthesis and biological studies

In what must surely be the shortest synthesis of an acridone alkaloid to date, 1-hydroxy-N-methylacridone 217 was prepared in a single step and 45% overall yield by condensing N-methylisatoic anhydride 218 with the potassium salt of cyclohexane-1,3-dione in DMSO at 110 °C over 18 hours.
80

Sharpless asymmetric dihydroxylation of acronycine 219 with the commercially available AD-mix- has given the (1R,2R)-()-cis-diol 220 in 40% enantiomeric excess (ee), while the enantiomeric diol ent-220 was obtained in 70% ee when AD-mix- was used. 81 The products could be purified by preparative chiral HPLC. This suite of reactions has served to establish the absolute configuration of the naturally occurring ()-cis-diol, an alkaloid that occurs in plants of the genus Sarcomelicope. Further confirmation of the configurations was provided by benzylic deoxygenation of 220 and ent-220 with sodium cyanoborohydride in the presence of zinc iodide to give the known alcohols 221 and ent-221, respectively. Acetylation of the diols produced the diesters 222 and ent-222. The two enantiomers of the diester showed essentially the same potent cytotoxicity towards L-1210 leukaemia cells in vitro (IC50 3.1 M for 222 and 3.7 mol for ent-222; cf. IC50 3.4 M for the racemate and 10.4 mol for acronycine itself ).

Further acronycine derivatives prepared for cytotoxicity studies include a range of racemic esters, ethers and amines 223–236, the enol acetate 237 and ketone 238, all derived by suitable manipulation of the racemic diol rac-220. 82 Access to the trans-series of compounds was obtained by equilibration of rac-220 with methanolic hydrochloric acid. Most of the new compounds exhibited only marginal cytotoxicity towards L-1210 leukaemia cells, but the chloroacetate esters 229 and 232 showed activities comparable to those of racemic diesters such as rac-222 (IC50 1.47 and 5.2 M respectively).

Two substantial studies on the effects of 15 different acridone and pyrano[2,3-c]acridone alkaloids on various cancer cells lines have cast light on the structural features needed for therapeutic efficacy. Four pyrano[2,3-c]acridone alkaloids in particular showed promising antiproliferative effects against tumour cell lines: atalaphyllidine 239, 5-hydroxy-N-methylseverifoline (N-methylatalaphyllinine) 240, atalaphyllinine 241 and des-N-methylnoracronycine 242. 83 The IC50 values displayed by these compounds in tests with human lung carcinoma, melanin-producing mouse melanoma, T-cell leukaemia and human gastric cancer cell (lymph-node metastasised) were in the range 1.4–9.4 M. Since these alkaloids had little effect on normal human cell lines, they may be useful as low-toxicity antitumour agents. Atalaphyllidine, des-N-methylnoracronycine and especially atalaphyllinine were able to induce differentiation of human promyelocytic leukaemia (HL-60) cells to produce characteristics of mature monocyte/macrophage cells, and also suppressed cell growth at 10 M concentrations by 30, 65 and 94% respectively after four days of growth. 84 Interestingly, at concentrations of 2.5 M, 5-hydroxynoracronycine 212 and alkaloids 239–241 stimulated cellular proliferation by 10–30% up to about the fourth day of growth.

References

1 A. Ito, L. A. Shamon, B. Yu, E. Mata-Greenwood, S. K. Lee, R. B. van Breemen, R. G. Mehta, N. R. Farnsworth, H. H. S. Fong, J. M. Pezzuto and A. D. Kinghorn, J. Agric. Food Chem., 1998, 46, 3509 [Links].
2 S.-L. Wu and W.-S. Li, Chin. Pharm. J. (Taipei), 1999, 51, 227; Chem. Abstr., 2000, 132, 61619.
3 T.-S. Wu, C.-Y. Li, Y.-L. Leu and C.-Q. Hu, Phytochemistry, 1999, 50, 509 [Links].
4 H.-K. Shin, J.-C. Do, J.-K. Son, C.-S. Lee, C.-H. Lee and C.-J. Cheong, Planta Med., 1998, 64, 764 [Links].
5 J. H. Rakotoson, N. Fabre, I. Jacquemond-Collet, S. Hannedouche, I. Fourasté and C. Moulis, Planta Med., 1998, 64, 762 [Links].
6 P. J. Houghton, T. Z. Woldemariam, Y. Watanabe and M. Yates, Planta Med., 1999, 65, 250 [Links].
7 A. K. Chakravarty, T. Sarkar, K. Masuda and K. Shiojima, Phytochemistry, 1999, 50, 1263 [Links].
8 S. Vajrodaya, M. Bacher, H. Greger and O. Hofer, Phytochemistry, 1998, 48, 897 [Links].
9 Y. Kashman, G. Koren-Goldshlager, M. D. G. Gravalos and M. Schleyer, Tetrahedron Lett., 1999, 40, 997 [Links].
10 T. H. Jones, J. S. T. Gorman, R. R. Snelling, J. H. C. Delabie, M. S. Blum, H. M. Garraffo, P. Jain, J. W. Daly and T. F. Spande, J. Chem. Ecol., 1999, 25, 1179.
11 C. Kamperdick, N. H. Van, T. V. Sung and G. Adam, Phytochemistry, 1999, 50, 177 [Links].
12 A. C. S. Baetas, M. S. P. Arruda, A. H. Muller and A. C. Arruda, J. Braz. Chem. Soc., 1999, 10, 181; Chem. Abstr., 1999, 131, 297605.
13 R. Pernin, F. Muyard, F. Bevalot, F. Tillequin and C. Moretti, Biochem. Syst. Ecol., 1999, 27, 531 [Links].
14 A. González, F. Schroeder, J. Meinwald and T. Eisner, J. Nat. Prod., 1999, 62, 378 [Links].
15 I. Kostova, A. Ivanova, B. Mikhova and I. Klaiber, Monatsh. Chem., 1999, 130, 703 [Links].
16 T.-S. Wu, Y.-L. Leu, Y.-Y. Chan, F.-W. Lin, C.-Y. Li, L.-S. Shi, S.-C. Kuo, C.-F. Chen and Y.-C. Wu, Phytochemistry, 1998, 49, 1467 [Links].
17 Atta-ur-Rahman, N. Sultana, S. Jahan and M. I. Choudhary, Nat. Prod. Lett., 1998, 12, 223.
18 T. F. Spande, P. Jain, H. M. Garraffo, L. K. Pannell, H. J. C. Yeh, J. W. Daly, S. Fukumoto, K. Imamura, T. Tokuyama, J. A. Torres, R. R. Snelling and T. H. Jones, J. Nat. Prod., 1999, 62, 5 [Links].
19 G. Roos , J.-H. Guse , I. Klaiber , B. Vogler , C. U. Walter and W. Kraus , in Natural Product Analysis, ed. P. Schreier, Vieweg, Wiesbaden, 1998, pp. 239–242 (Chem. Abstr., 1999, 131, 269556).
20 I.-L. Tsai, M.-F. Wun, C.-M. Teng, T. Ishikawa and I.-S. Chen, Phytochemistry, 1998, 48, 1377 [Links].
21 I.-S. Chen, T.-L. Chen, Y.-L. Chang, C.-M. Teng and W.-Y. Lin, J. Nat. Prod., 1999, 62, 833 [Links].
22 L. E. Cuca S., J. C. Martinez V. and F. Delle Monache, Rev. Colomb. Quím., 1998, 27, 17; Chem. Abstr., 1999, 131, 127636.
23 V. A. Facundo, S. Maia de Morais, R. B. Filho, F. J. de A. Matos and R. T. Souza, Rev. Bras. Farm., 1997, 78, 57; Chem. Abstr., 1999, 130, 242194.
24 I. Mester, Fitoterapia, 1973, 44, 123 [Links].
25 (a) J. P. Michael, Nat. Prod. Rep., 1999, 16, 697 [Links]. (b) J. P. Michael, Nat. Prod. Rep., 1999, 16, 702. (c) J. P. Michael, Nat. Prod. Rep., 1998, 15, 600. (d) J. P. Michael, Nat. Prod. Rep., 1997, 14, 613. (e) J. P. Michael, Nat. Prod. Rep., 1999, 16, 704. (f) J. P. Michael, Nat. Prod. Rep., 1999, 16, 706. (g) J. P. Michael, Nat. Prod. Rep., 1997, 14, 612.
26 S. Al-Khalil, A. Alkofahi, D. El-Eisawi and A. Al-Shibib, J. Nat. Prod., 1999, 62, 1214 [Links].
27 S. Al-Khalil, A. Alkofahi, D. El-Eisawi and A. Al-Shibib, J. Nat. Prod., 1998, 61, 262 [Links].
28 R. S. Varma and D. Kumar, Tetrahedron Lett., 1998, 39, 9113 [Links].
29 D. C. Harrowven and M. I. T. Nunn, Tetrahedron Lett., 1998, 39, 5875 [Links].
30 O. Yamada and K. Ogasawara, Tetrahedron Lett., 1998, 39, 7747 [Links].
31 M. C. Pirrung and F. Blume, J. Org. Chem., 1999, 64, 3642 [Links].
32 M. Tori, T. Shimoji, S. Takaoka, K. Nakashima, M. Sono and W. A. Ayer, Tetrahedron Lett., 1999, 40, 323 [Links].
33 D. L. Comins, A. H. Libby, R. S. Al-awar and C. J. Foti, J. Org. Chem., 1999, 64, 2184 [Links].
34 D. L. Comins, C. J. Foti and A. H. Libby, Heterocycles, 1998, 48, 1313.
35 S. Yoo, J. Kim and K. Y. Yi, Bull. Korean Chem. Soc., 1999, 20, 139.
36 R. Crous, C. Dwyer and C. W. Holzapfel, Heterocycles, 1999, 91, 721.
37 D. L. Boger, M. W. Ledeboer and M. Kume, J. Am. Chem. Soc., 1999, 121, 1098 [Links].
38 M. A. Ciufolini, D. Valognes and N. Xi, Tetrahedron Lett., 1999, 40, 3693 [Links].
39 D. L. Boger and K. W. Saionz, Bioorg. Med. Chem., 1999, 7, 315 [Links].
40 H. Quast and E. Schmitt, Liebigs Ann. Chem., 1970, 732, 43.
41 Y. Tagawa, H. Yamashita, M. Nomura and Y. Goto, Heterocycles, 1998, 48, 2379.
42 J. W. Daly , H. M. Garraffo and T. F. Spande , in Alkaloids: Chemical and Biological Perspectives, ed. S. W. Pelletier, Pergamon Press, Amsterdam, 1999, vol. 13, pp. 1–161.
43 H. M. Garraffo, T. F. Spande, T. H. Jones and J. W. Daly, Rapid Commun. Mass Spectrom., 1999, 13, 1553 [Links].
44 T. G. Back and K. Nakajima, Tetrahedron Lett., 1997, 38, 989 [Links].
45 T. G. Back and K. Nakajima, J. Org. Chem., 1998, 63, 6566 [Links].
46 T. Riechers, H. C. Krebs, R. Wartchow and G. Habermehl, Eur. J. Org. Chem., 1998, 2641 [Links].
47 M. Weymann, M. Schultz-Kukula and H. Kunz, Tetrahedron Lett., 1998, 39, 7835 [Links].
48 D. L. Comins and A. Dehghani, J. Chem. Soc., Chem. Commun., 1993, 1839 [Links].
49 N. Toyooka, M. Okumura and H. Takahata, J. Org. Chem., 1999, 64, 2182 [Links].
50 L. Rahbæk, J. Breinholt, J. C. Frisvad and C. Christophersen, J. Org. Chem., 1999, 64, 1689 [Links].
51 L. Rahbæk and J. Breinholt, J. Nat. Prod., 1999, 62, 904 [Links].
52 J. Yamahara and M. Nomura , Jpn. Kokai Tokkyo Koho, JP 11029489 A2 19990202 Heisei (Chem. Abstr., 1999, 130, 172751).
53 C. Seger, S. Vajrodaya, H. Greger and O. Hofer, Chem. Pharm. Bull., 1998, 46, 1926.
54 B. K. Joshi, J. B. Gloer, D. T. Wicklow and P. F. Dowd, J. Nat. Prod., 1999, 62, 650 [Links].
55 T. O. Larsen, K. Frydenvang, J. C. Frisvad and C. Christophersen, J. Nat. Prod., 1998, 61, 1154 [Links].
56 A. Ikuta, H. Urabe and T. Nakamura, J. Nat. Prod., 1998, 61, 1012 [Links].
57 D. R. Harrison, P. D. Kennewell and J. B. Taylor, J. Heterocycl. Chem., 1977, 14, 1191.
58 J. Muthukrishnan, K. Seifert, K. H. Hoffmann and M. W. Lorenz, Phytochemistry, 1999, 50, 249 [Links].
59 L. A. Mitscher and W. Baker, Med. Res. Rev., 1998, 18, 363 [Links].
60 I. Ojima and D. M. Iula , in Alkaloids: Chemical and Biological Perspectives, ed. S. W. Pelletier, Pergamon Press, Amsterdam, 1999, vol. 13, pp. 403–405.
61 B. S. Joshi, M. G. Newton, D. W. Lee, A. D. Barber and S. W. Pelletier, Tetrahedron: Asymmetry, 1996, 7, 25 [Links].
62 B. S. Joshi and S. W. Pelletier, Heterocycles, 1999, 51, 183.
63 S. Kobayashi, M. Ueno, R. Suzuki and H. Ishitani, Tetrahedron Lett., 1999, 40, 2175 [Links].
64 Y. Takeuchi, H. Abe and T. Harayama, Chem. Pharm. Bull., 1999, 47, 905.
65 H. Wang and A. Ganesan, Tetrahedron Lett., 1998, 39, 9097 [Links].
66 T. R. Kelly, S. Chamberland and R. A. Silva, Tetrahedron Lett., 1999, 40, 2723 [Links].
67 T. Sugimori, T. Okawa, S. Eguchi, A. Kakehi, E. Yashima and Y. Okamoto, Tetrahedron, 1998, 54, 7997 [Links].
68 T. Sugimori, T. Okawa, S. Eguchi, E. Yashima and Y. Okamoto, Chem. Lett., 1997, 869 [Links].
69 H. H. Sun, C. J. Barrow and R. Cooper, J. Nat. Prod., 1995, 58, 1575 [Links].
70 H. Wang and A. Ganesan, J. Org. Chem., 1998, 63, 2432 [Links].
71 F. He and B. B. Snider, J. Org. Chem., 1999, 64, 1397 [Links].
72 P. Cledera, C. Avendaño and J. C. Menéndez, Tetrahedron, 1998, 54, 12349 [Links].
73 D. J. Hart and N. Magomedov, J. Org. Chem., 1999, 64, 2990 [Links].
74 S. Jolivet-Fouchet, F. Fabis, P. Bovy, P. Ochsenbein and S. Rault, Heterocycles, 1999, 51, 1257.
75 A. M. El-Shafae and A. S. Soliman, Pharmazie, 1998, 53, 640.
76 Y. Takemura, M. Ju-ichi, M. Omura, C. Ito and H. Furukawa, Heterocycles, 1999, 51, 851.
77 Y. Takemura, J. Takaya, Y. Okamura, Y. Arima, T. Atarashi, N. Nagareya, M. Ju-ichi, M. Omura, C. Ito and H. Furukawa, Chem. Pharm. Bull., 1998, 46, 1518.
78 N. Sultana, T. G. Hartley and P. G. Waterman, Phytochemistry, 1999, 50, 1249 [Links].
79 V. S. Parmar, S. C. Jain, S. Gupta, S. Talwar, V. K. Rajwanshi, R. Kumar, A. Azim, S. Malhotra, N. Kumar, R. Jain, N. K. Sharma, O. D. Tyagi, S. J. Lawrie, W. Errington, O. W. Howarth, C. E. Olsen, S. K. Singh and J. Wengel, Phytochemistry, 1998, 49, 1069 [Links].
80 G. M. Coppola, Org. Prep. Proc. Int., 1999, 31, 225.
81 N. Costes, S. Michel, F. Tillequin, M. Koch, A. Pierré and G. Atassi, J. Nat. Prod., 1999, 62, 490 [Links].
82 P. Magiatis, S. Mitaku, A.-L. Skaltsounis, F. Tillequin, M. Koch, A. Pierré and G. Atassi, Chem. Pharm. Bull., 1999, 47, 611.
83 S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, M. Yano, Y. Takemura, M. Ju-ichi, C. Ito and H. Furukawa, J. Nat. Prod., 1999, 62, 587 [Links].
84 S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, M. Yano, Y. Takemura, M. Ju-ichi, C. Ito and H. Furukawa, Leukemia Res., 1999, 23, 263.

This journal is © The Royal Society of Chemistry 2000